All Labs
 
BOOK LAB TESTS! Get 50% Off
add to cart

Coombs Test - Indirect

500250
50% Coupon
4.1
NABL, CAP, ISO
ADD TO CART
Overview
Test Results & Interpretations

Overview of Coombs Test - Indirect

Test Description

The Indirect Coombs test is performed to screen for the presence of antibodies against Red Blood Cells (RBCs). If present, these antibodies will target and destroy foreign RBCs acquired through blood transfusions, or those present in the fetus by the antibodies of the mother.

Why Get Tested

  1. To screen the recipient of a blood transfusion before the transfusion is done
  2. To screen the mother’s blood for antigens that can target the RBCs of the newborn
  3. To detect type of anemia
  4. For evaluation of hemolytic anemia

Precautions

  • No special preparation required

What Results of Coombs Test - Indirect mean?

Interpretations

Positive results for the Indirect Coombs test indicates that antibodies against one or more antigens being screened are present in the blood sample being tested. When tested positive in a pregnant woman, it indicates the presence of Rh antibody in the mother’s blood that may destroy the RBCs of the baby in some cases.

Provided By

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.

Available at Other Labs

VIEW ALL